FRANKFURT, Germany--(BUSINESS WIRE)--Andreae-Noris Zahn AG (ANZAG)(GER:ANZ)(FWB:FANZ) yesterday signed a share purchase agreement to acquire a 92-per-cent stake in Lithuanian pharmaceutical wholesaler JSC Armila. “By acquiring Armila, we are expanding our business in foreign markets, and so reducing our dependency on our home market of Germany, and our vulnerability to cyclical fluctuations here,” says Thomas Trümper, Chairman of the Board of ANZAG.
